Adaptive Medicine Limitation Management for Infusion Pumps

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing medicine information management systems for medical equipment, such as infusion pumps, rely on uniformly defined limitations that may not be optimal due to advancements in medicine, leading to potential inaccuracies in dosage restrictions.

Innovation Solution

A medicine information management device and method that generate and store administration-level information associated with medicine usage, including trouble information and limitation data, to analyze and display alert occurrence frequencies and limitation ranges, enabling Continuous Quality Improvement (CQI) by suggesting changes to these limitations.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If uniformly defined medicine limitations are used, then the system is simple and easy to operate, but the accuracy and optimality of dosage restrictions deteriorate over time due to medical advancements

Engineering Contradiction:
Improvesimplicity of limitation definitionVSAvoidaccuracy of dosage restriction
Core Design Contradiction:
Ease of operationVSMeasurement precision

Solution Approach 1:

The patent transforms static, uniformly defined medicine limitations into dynamic, data-driven limitations. By continuously collecting actual usage data from medical equipment and analyzing trouble information, the system automatically updates limitation values to reflect current medical standards and real-world performance, making the limitations adaptive rather than fixed.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent implements a feedback mechanism where actual medicine usage data and trouble information are continuously fed back into the limitation determination process. The system analyzes this feedback data to identify patterns and adjust limitation values, creating a closed-loop system that self-improves over time rather than relying on static predefined values.

Inventive Principle:
Principle #23Feedback

2Device complexity

If uniform medicine limitations are applied across all cases, then the device complexity is reduced, but the reliability of medicine usage safety deteriorates due to inability to adapt to new medical developments

Engineering Contradiction:
Improvecomplexity of limitation systemVSAvoidsafety of medicine usage
Core Design Contradiction:
Device complexityVSReliability

Solution Approach 1:

The patent enables the limitation system to serve itself by automatically collecting usage data, analyzing trouble patterns, and updating limitation values without requiring manual intervention from medical professionals. The system self-updates its limitation parameters based on accumulated real-world data, reducing the need for external configuration while improving reliability.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent performs preliminary data collection and analysis to establish evidence-based limitations before they are applied. By gathering usage data and analyzing trouble information in advance, the system determines optimized limitation values that are grounded in actual performance data rather than theoretical assumptions, improving safety before deployment.

Inventive Principle:
Principle #10Preliminary action

3Measurement precision

If actual usage data is collected and analyzed, then the optimality of medicine limitations is improved, but the loss of time for data processing and analysis increases

Engineering Contradiction:
Improveoptimality of limitation informationVSAvoidtime for data processing
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent implements continuous data collection and analysis rather than periodic batch processing. The system continuously monitors medicine usage and trouble information, performing real-time or near-real-time analysis to maintain up-to-date limitation values without requiring dedicated processing time intervals, thus minimizing time loss while maintaining precision.

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The patent applies partial analysis by focusing on specific trouble patterns and usage scenarios that are most relevant to limitation optimization. Rather than analyzing all possible data equally, the system identifies and processes only the most critical data points, reducing processing time while maintaining the quality of limitation determination.

Inventive Principle:
Principle #16Partial or excessive action

Data Source

PatentEP2759979B1Drug information management device and drug information management method
Publication Date: 2022.08.17 TERUMO KK
  • EP2759979B1 patent drawingFigure 1
  • EP2759979B1 patent drawingFigure 2
  • EP2759979B1 patent drawingFigure 3

AI summary

It is to provide a medicine information management device and so on that enables CQI of information on a use limitation or the like of a medicine used in medical equipment and so on. There is provided a medicine information management device 10 including: generating and storing administration-level-information-associated information on the number of doses that is actual information on the number of doses of administration level information; storing medicine limitation information that is limitation information for a use of a medicine in association with administration level information; storing trouble information generated when the medicine is actually used in the administration level information, in association with the medicine information and the administration level information; generating and storing number-of-doses-and-level-associated information on the number and level of troubles based on number information of the trouble information and the administration-level-information-associated information on the number of doses; generating medicine analysis information to show the number-of-doses-and-level-associated information on the number and level of troubles and the medicine limitation information as information associated with the administration-level-information-associated information on the number of doses; and displaying this medicine analysis information on a display unit 4a of a subject side terminal 3a.